Yuanmin Li

301 Yan Chang Zhong Road
Shanghai, 200072, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

FOXP1‑induced DUSP12 alleviates vascular endothelial cell inflammation and oxidative stress injury induced by ox‑LDL via MAP3K5 signaling pathway.

FOXP1‑induced DUSP12 alleviates vascular endothelial cell inflammation and oxidative stress injury induced by ox‑LDL via MAP3K5 signaling pathway.

Journal: Experimental and therapeutic medicine

Published: February 13, 2023

S100A1 as a potential biomarker for the diagnosis of patients with acute aortic dissection.

S100A1 as a potential biomarker for the diagnosis of patients with acute aortic dissection.

Journal: The Journal of international medical research

Published: April 07, 2021

Salidroside protects against cardiomyocyte apoptosis and ventricular remodeling by AKT/HO-1 signaling pathways in a diabetic cardiomyopathy mouse model.

Salidroside protects against cardiomyocyte apoptosis and ventricular remodeling by AKT/HO-1 signaling pathways in a diabetic cardiomyopathy mouse model.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 21, 2020

Circulating Matrix Metalloproteinase-28 Levels Are Related to GRACE Scores and Short-Term Outcomes in Patients with Acute Myocardial Infarction.

Circulating Matrix Metalloproteinase-28 Levels Are Related to GRACE Scores and Short-Term Outcomes in Patients with Acute Myocardial Infarction.

Journal: BioMed research international

Published: January 31, 2020

Targeted depletion of monocyte/macrophage suppresses aortic dissection with the spatial regulation of MMP-9 in the aorta.

Targeted depletion of monocyte/macrophage suppresses aortic dissection with the spatial regulation of MMP-9 in the aorta.

Journal: Life sciences

Published: July 18, 2019

Cardioprotection of salvianolic acid B and ginsenoside Rg1 combination on subacute myocardial infarction and the underlying mechanism.

Cardioprotection of salvianolic acid B and ginsenoside Rg1 combination on subacute myocardial infarction and the underlying mechanism.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: September 29, 2018

Association between serum S100A1 level and Global Registry of Acute Coronary Events score in patients with non-ST-segment elevation acute coronary syndrome.

Association between serum S100A1 level and Global Registry of Acute Coronary Events score in patients with non-ST-segment elevation acute coronary syndrome.

Journal: The Journal of international medical research

Published: May 16, 2018

Salidroside Protects Against Advanced Glycation End Products-Induced Vascular Endothelial Dysfunction.

Salidroside Protects Against Advanced Glycation End Products-Induced Vascular Endothelial Dysfunction.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: April 22, 2018

Salidroside protects against foam cell formation and apoptosis, possibly via the MAPK and AKT signaling pathways.

Salidroside protects against foam cell formation and apoptosis, possibly via the MAPK and AKT signaling pathways.

Journal: Lipids in health and disease

Published: August 23, 2017

Cardio-protection of ultrafine granular powder for Salvia miltiorrhiza Bunge against myocardial infarction.

Cardio-protection of ultrafine granular powder for Salvia miltiorrhiza Bunge against myocardial infarction.

Journal: Journal of ethnopharmacology

Published: August 18, 2017

In Patients with Coronary Artery Disease and Type 2 Diabetes, SIRT1 Expression in Circulating Mononuclear Cells Is Associated with Levels of Inflammatory Cytokines but Not with Coronary Lesions.

In Patients with Coronary Artery Disease and Type 2 Diabetes, SIRT1 Expression in Circulating Mononuclear Cells Is Associated with Levels of Inflammatory Cytokines but Not with Coronary Lesions.

Journal: BioMed research international

Published: December 06, 2015

Elevated plasma level of pentraxin-3 predicts in-hospital and 30-day clinical outcomes in patients with non-ST-segment elevation myocardial infarction who have undergone percutaneous coronary intervention.

Elevated plasma level of pentraxin-3 predicts in-hospital and 30-day clinical outcomes in patients with non-ST-segment elevation myocardial infarction who have undergone percutaneous coronary intervention.

Journal: Cardiology

Published: March 27, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026